Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions
- 31 December 1986
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 8 (3) , 277-286
- https://doi.org/10.1016/0192-0561(86)90109-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Inhibition of human and guinea pig complement by heparin fractions differing in affinity for antithrombin III or in average molecular weightInternational Journal of Immunopharmacology, 1985
- Complement depletion accelerates the clearance of immune complexes from the circulation of primates.Journal of Clinical Investigation, 1984
- Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMolecular Immunology, 1983
- Inhibition of the Interaction between the Complement Component Clq and Immune ComplexesInternational Archives of Allergy and Immunology, 1979
- Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombinFEBS Letters, 1976
- The separation of active and inactive forms of heparinBiochemical and Biophysical Research Communications, 1976
- Inactivator of the First Component of Human Complement (CĪINA)International Archives of Allergy and Immunology, 1976
- Effect of C′1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edemaJournal of Clinical Investigation, 1968
- The Discovery of HeparinCirculation, 1959
- Anticomplementary Power of HeparinThe Journal of Infectious Diseases, 1929